Regions Financial Corp’s ResMed RMD Stock Holding History

Regions Financial Corp’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-110	Closed	-$11K	–	2081
2018 Q2	$11K	Buy	+110	New	+$11.1K	﹤0.01%	1623
2014 Q3	–	Sell	-5,961	Closed	-$302K	–	1135
2014 Q2	$302K	Buy	5,961 +695	+13%	+$34.4K	﹤0.01%	940
2014 Q1	$235K	Buy	5,266 +946	+22%	+$42.5K	﹤0.01%	1007
2013 Q4	$204K	Buy	+4,320	New	+$219K	﹤0.01%	1066

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Regions Financial Corp's RMD Position: Q3 2018 in Review

Regions Financial Corp sold out of ResMed (RMD) in Q3 2018, closing a stake of 110 shares — an estimated $11K sold.

Regions Financial Corp first reported a position in RMD in Q4 2013 and held it in 4 quarters. The position peaked at $302K in Q2 2014. 497 funds tracked by Wall St. Rank hold RMD as of Q3 2018.

Regions Financial Corp reported no remaining ResMed position as of Q3 2018 after selling out during the quarter.
Regions Financial Corp sold 110 ResMed shares in Q3 2018, an estimated $11K.
Regions Financial Corp first reported a position in ResMed in Q4 2013 and held it in 4 quarters.
Regions Financial Corp's ResMed position peaked at $302K in Q2 2014.
497 funds tracked by Wall St. Rank held ResMed as of Q3 2018.

Based on Regions Financial Corp's 13F filing for Q3 2018, filed 22 Oct 2018.